HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,910,312 | +191031100.0% | 21,325 | -21.7% | 0.01% | – |
| Q2 2023 | $1 | -99.9% | 27,241 | +21.6% | 0.00% | -100.0% |
| Q4 2022 | $1,924 | -99.9% | 22,405 | -3.3% | 0.02% | -6.2% |
| Q3 2022 | $1,860,000 | -13.9% | 23,160 | -30.8% | 0.02% | -11.1% |
| Q2 2022 | $2,160,000 | -9.4% | 33,448 | -19.5% | 0.02% | +5.9% |
| Q1 2022 | $2,384,000 | -56.2% | 41,534 | -62.4% | 0.02% | -57.5% |
| Q4 2021 | $5,440,000 | -27.0% | 110,503 | +6.4% | 0.04% | -11.1% |
| Q3 2021 | $7,449,000 | +364.1% | 103,820 | +273.2% | 0.04% | +350.0% |
| Q2 2021 | $1,605,000 | -16.5% | 27,820 | -2.4% | 0.01% | -9.1% |
| Q1 2021 | $1,922,000 | -45.3% | 28,491 | -5.2% | 0.01% | -50.0% |
| Q4 2020 | $3,513,000 | +6.7% | 30,044 | -2.4% | 0.02% | -8.3% |
| Q3 2020 | $3,291,000 | +16.4% | 30,770 | +0.1% | 0.02% | +9.1% |
| Q2 2020 | $2,828,000 | -35.6% | 30,726 | -18.3% | 0.02% | -45.0% |
| Q1 2020 | $4,388,000 | -0.2% | 37,592 | -6.5% | 0.04% | +21.2% |
| Q4 2019 | $4,395,000 | -2.3% | 40,199 | +7.4% | 0.03% | -8.3% |
| Q3 2019 | $4,499,000 | -3.2% | 37,431 | -1.7% | 0.04% | -2.7% |
| Q2 2019 | $4,646,000 | +22.5% | 38,085 | -10.9% | 0.04% | +19.4% |
| Q1 2019 | $3,794,000 | -10.2% | 42,725 | -3.0% | 0.03% | -13.9% |
| Q4 2018 | $4,225,000 | +0.8% | 44,034 | +11.9% | 0.04% | +5.9% |
| Q3 2018 | $4,191,000 | +0.3% | 39,341 | -8.7% | 0.03% | +17.2% |
| Q2 2018 | $4,179,000 | -7.6% | 43,096 | -27.9% | 0.03% | -9.4% |
| Q1 2018 | $4,524,000 | +19.4% | 59,737 | +3.3% | 0.03% | +28.0% |
| Q4 2017 | $3,790,000 | +24.4% | 57,855 | -10.6% | 0.02% | +13.6% |
| Q3 2017 | $3,047,000 | +16.1% | 64,687 | -1.5% | 0.02% | +10.0% |
| Q2 2017 | $2,625,000 | -8.6% | 65,703 | -3.8% | 0.02% | -9.1% |
| Q1 2017 | $2,872,000 | +28.8% | 68,285 | +23.9% | 0.02% | +22.2% |
| Q4 2016 | $2,230,000 | +17.9% | 55,134 | +6.2% | 0.02% | +12.5% |
| Q3 2016 | $1,892,000 | +4.0% | 51,901 | +1.9% | 0.02% | 0.0% |
| Q2 2016 | $1,820,000 | +1.6% | 50,950 | -2.8% | 0.02% | 0.0% |
| Q1 2016 | $1,792,000 | +12.3% | 52,405 | -0.4% | 0.02% | 0.0% |
| Q4 2015 | $1,596,000 | -5.6% | 52,596 | +0.6% | 0.02% | 0.0% |
| Q3 2015 | $1,690,000 | -61.6% | 52,275 | -50.8% | 0.02% | -15.8% |
| Q2 2015 | $4,396,000 | +87.6% | 106,280 | +103.8% | 0.02% | -5.0% |
| Q1 2015 | $2,343,000 | -38.6% | 52,152 | -48.9% | 0.02% | +25.0% |
| Q4 2014 | $3,816,000 | +112.2% | 101,978 | +98.1% | 0.02% | 0.0% |
| Q3 2014 | $1,798,000 | -1.3% | 51,488 | -0.3% | 0.02% | +6.7% |
| Q2 2014 | $1,822,000 | +7.2% | 51,639 | -1.0% | 0.02% | +15.4% |
| Q1 2014 | $1,700,000 | -28.0% | 52,167 | -6.9% | 0.01% | -27.8% |
| Q4 2013 | $2,361,000 | -6.2% | 56,053 | -11.2% | 0.02% | 0.0% |
| Q3 2013 | $2,518,000 | -0.4% | 63,147 | +3.2% | 0.02% | -14.3% |
| Q2 2013 | $2,529,000 | – | 61,163 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |